The Sustained Viral Resilience Programme sits within the Sculpting Innate Immunity opportunity space and seeks to create a new class of medicines that provide durable, broad-spectrum protection against respiratory viruses by engineering the innate immune system. The programme’s focus areas are TA1 – Explorers, which aim to provide compelling proof-of-concept evidence that SIIPs are possible
Access Restricted: Members-Only Content. We're sorry, but this content is available exclusively to our subscribed members: